← Evidence map

ArticleActa pharmaceutica Sinica. B2022

Targeting PFKL with penfluridol inhibits glycolysis and suppresses esophageal cancer tumorigenesis in an AMPK/FOXO3a/BIM-dependent manner.

Cancan Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

53 papers cite it

2022
2023
2024
2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35530161